Furthermore, this functional recovery was associated with a significant reduction in cardiac fibrosis markers, including Galectin-3, Col1a3, Col1a1, and TGF-β activity, upon NU7441 treatment 120, 121. This evidence concerns the gene TGFB1 and fibrosis.